Lena Fung

Professional Overview

Lena Fung is an experienced corporate development professional serving as the Director of Corporate Development at the Cholangiocarcinoma Foundation. With a strong background in strategic planning, business development, and financial analysis, Lena leverages her expertise to drive growth and optimize operational efficiency within the healthcare industry.

Current Role

As the Director of Corporate Development at the Cholangiocarcinoma Foundation, Lena is responsible for spearheading the organization's long-term strategic initiatives. She oversees a range of critical functions, including mergers and acquisitions, joint ventures, and strategic partnerships. Lena's contributions have been instrumental in expanding the Foundation's reach and securing new revenue streams to further its mission of advancing research and patient care related to cholangiocarcinoma.

Career Progression

Prior to her current role, Lena held the position of Senior Analyst at a leading healthcare consulting firm, where she provided strategic insights and recommendations to clients across the industry. Her analytical prowess and ability to identify growth opportunities led to her swift career advancement. Lena's diverse experience, coupled with her strong problem-solving and communication skills, have allowed her to make meaningful contributions to the organizations she has served.

Academic Background

Lena holds a Bachelor of Science in Finance from the University of Florida, where she graduated with honors. She further honed her financial acumen by earning a Master of Business Administration degree from the University of Miami, with a specialization in healthcare management.

Areas of Expertise

• Strategic planning and execution

• Corporate development and M&A

• Financial analysis and modeling

• Business development and partnership management

• Healthcare industry knowledge and regulatory compliance

Professional Impact

During her tenure at the Cholangiocarcinoma Foundation, Lena has spearheaded the development and implementation of a comprehensive growth strategy, resulting in the successful acquisition of two complementary organizations. This strategic move has expanded the Foundation's service offerings and significantly increased its geographic reach, enabling it to serve a larger patient population. Additionally, Lena has leveraged her financial expertise to streamline operational processes, leading to a 15% improvement in cost efficiency.

Conclusion

Lena Fung's extensive experience in corporate development, coupled with her deep understanding of the healthcare industry, positions her as a valuable asset to the Cholangiocarcinoma Foundation. Her strategic vision, analytical capabilities, and proven track record of driving growth and operational excellence make her a trusted leader within the organization. Lena is committed to continuing her contributions to the Foundation's mission and expanding its impact on the lives of those affected by cholangiocarcinoma.